ATE283049T1 - Antibakterielle verbindungen - Google Patents

Antibakterielle verbindungen

Info

Publication number
ATE283049T1
ATE283049T1 AT00936459T AT00936459T ATE283049T1 AT E283049 T1 ATE283049 T1 AT E283049T1 AT 00936459 T AT00936459 T AT 00936459T AT 00936459 T AT00936459 T AT 00936459T AT E283049 T1 ATE283049 T1 AT E283049T1
Authority
AT
Austria
Prior art keywords
antibacterial compounds
antibacterial
compounds
Prior art date
Application number
AT00936459T
Other languages
English (en)
Inventor
William H Miller
Kenneth A Newlander
Mark Seefeld
Original Assignee
Affinium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinium Pharm Inc filed Critical Affinium Pharm Inc
Application granted granted Critical
Publication of ATE283049T1 publication Critical patent/ATE283049T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00936459T 1999-06-01 2000-06-01 Antibakterielle verbindungen ATE283049T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13700499P 1999-06-01 1999-06-01
PCT/US2000/015154 WO2000072846A1 (en) 1999-06-01 2000-06-01 Antibacterial compounds

Publications (1)

Publication Number Publication Date
ATE283049T1 true ATE283049T1 (de) 2004-12-15

Family

ID=22475391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00936459T ATE283049T1 (de) 1999-06-01 2000-06-01 Antibakterielle verbindungen

Country Status (23)

Country Link
US (2) US6573272B1 (de)
EP (1) EP1180030B1 (de)
JP (1) JP4733836B2 (de)
KR (1) KR20020005767A (de)
CN (1) CN1365280A (de)
AR (1) AR024158A1 (de)
AT (1) ATE283049T1 (de)
AU (1) AU773550B2 (de)
BR (1) BR0011121A (de)
CA (1) CA2375630A1 (de)
CO (1) CO5370679A1 (de)
CZ (1) CZ20014290A3 (de)
DE (1) DE60016198T2 (de)
HK (1) HK1045644A1 (de)
HU (1) HUP0201206A3 (de)
IL (1) IL146514A0 (de)
MX (1) MXPA01012326A (de)
NO (1) NO20015722D0 (de)
NZ (1) NZ515611A (de)
PL (1) PL351959A1 (de)
TR (1) TR200103485T2 (de)
WO (1) WO2000072846A1 (de)
ZA (1) ZA200109733B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
CO5370679A1 (es) 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
WO2001026652A1 (en) * 1999-10-08 2001-04-19 Smithkline Beecham Corporation Fab i inhibitors
HU230030B1 (hu) 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
US6730684B1 (en) * 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US6987115B2 (en) 2000-12-08 2006-01-17 Smithkline Beecham Corporation Antibacterial compounds
AU2002237731B2 (en) * 2000-12-21 2007-03-22 Michael J. Kirisits Fab I and inhibition of apicomplexan parasites
ES2248412T3 (es) * 2001-02-12 2006-03-16 Lilly Icos Llc Derivados de carbolina.
EP1560584B1 (de) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab-i-inhibitoren
EP1575951B1 (de) * 2002-12-06 2014-06-25 Debiopharm International SA Heterozyclische verbindungen, verfahren zu deren herstellung und ihre verwendung als heilmittel
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
JP2006525347A (ja) * 2003-04-29 2006-11-09 オシエント ファーマシューティカルズ 抗生テトラヒドロ−β−カルボリン誘導体
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
US7854963B2 (en) * 2006-10-13 2010-12-21 Solopower, Inc. Method and apparatus for controlling composition profile of copper indium gallium chalcogenide layers
EP2125802A4 (de) 2007-02-16 2014-08-20 Debiopharm Int Sa Salze, prodrugs und polymorphe von fab-i-inhibitoren
WO2009073534A2 (en) 2007-11-30 2009-06-11 Maxthera Inc. Bicyclic ppat inhibitors as antibacterial agents
KR101135179B1 (ko) * 2009-02-20 2012-04-16 한국생명공학연구원 ＦａｂＩ 저해 물질 비나산손을 포함하는 항균용 조성물
WO2012127885A1 (ja) 2011-03-18 2012-09-27 小野薬品工業株式会社 テトラヒドロカルボリン誘導体
AU2013279021C1 (en) 2012-06-19 2017-03-16 Debiopharm International Sa Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
JP2021534246A (ja) * 2018-08-16 2021-12-09 レクレオ ファーマシューティカルス アイエヌシー １，３，４，９−テトラヒドロ−２ｈ−ピリド［３，４−ｂ］インドール誘導体化合物及びその使用
TN2021000159A1 (en) 2019-02-14 2023-04-04 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
SG11202113174SA (en) 2019-06-14 2021-12-30 Debiopharm Int Sa Medicament and use thereof for treating bacterial infections involving biofilm

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828068A (en) 1971-05-10 1974-08-06 Tenneco Chem ((substituted indazolyl)-n1-methyl)carbamates
US4154943A (en) 1977-12-29 1979-05-15 University Of Vermont Preparation of vincadifformine
US4267330A (en) * 1978-08-24 1981-05-12 Omnium Chimique Societe Anonyme Process for the synthesis of vincadifformine and related derivatives
FR2619111B1 (fr) * 1987-08-07 1991-01-11 Synthelabo Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5416193A (en) * 1993-04-30 1995-05-16 Pfizer Inc. Coupling reagent and method
MA23420A1 (fr) 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US5614551A (en) 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
NZ290008A (en) 1994-06-29 1998-08-26 Smithkline Beecham Corp Vitronectin receptor antagonists, comprising a fibrinogen antagonist analogue linked to a heterocycle
DE19624659A1 (de) 1996-06-20 1998-01-08 Klinge Co Chem Pharm Fab Neue Pyridylalken- und Pyridylalkinsäureamide
US6451816B1 (en) 1997-06-20 2002-09-17 Klinge Pharma Gmbh Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
JPH10310582A (ja) * 1997-03-13 1998-11-24 Sankyo Co Ltd ピペリジン環縮合カルバペネム化合物
AU6870098A (en) 1997-03-31 1998-10-22 Du Pont Merck Pharmaceutical Company, The Indazoles of cyclic ureas useful as hiv protease inhibitors
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US5932743A (en) 1997-08-21 1999-08-03 American Home Products Corporation Methods for the solid phase synthesis of substituted indole compounds
DK1042287T3 (da) * 1997-12-24 2005-08-15 Aventis Pharma Gmbh Indolderivater som inhibitorer af faktor Xa
HUP0103622A3 (en) * 1998-08-20 2003-01-28 Agouron Pharmaceuticals Inc La Non-peptide gnrh agents, methods and intermediates for their preparation and medicaments containing them
GT199900167A (es) * 1998-10-01 2001-03-21 Nuevos bis-benzimidazoles.
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
AR024077A1 (es) 1999-05-25 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
CO5370679A1 (es) 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
CO5180605A1 (es) 1999-06-23 2002-07-30 Smithkline Beecham Corp Compuestos de indol
US6346391B1 (en) 1999-07-22 2002-02-12 Trustees Of Tufts College Methods of reducing microbial resistance to drugs
ATE294578T1 (de) 1999-10-08 2005-05-15 Affinium Pharm Inc Fab i hemmer
HU230030B1 (hu) 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
WO2001026652A1 (en) 1999-10-08 2001-04-19 Smithkline Beecham Corporation Fab i inhibitors
US6503908B1 (en) 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds
US6656703B1 (en) 1999-12-29 2003-12-02 Millennium Pharamaceuticals, Inc. High throughput screen for inhibitors of fatty acid biosynthesis in bacteria
US6372752B1 (en) 2000-02-07 2002-04-16 Genzyme Corporation Inha inhibitors and methods of use thereof
EP1332131A2 (de) 2000-11-07 2003-08-06 Bristol-Myers Squibb Company Säurederivate und ihre verwendung als inhibitoren von serinproteasen
US20020107266A1 (en) 2000-12-12 2002-08-08 Marguerita Lim-Wilby Compounds, compositions and methods for treatment of parasitic infections

Also Published As

Publication number Publication date
PL351959A1 (en) 2003-07-14
ZA200109733B (en) 2002-09-11
DE60016198D1 (de) 2004-12-30
CN1365280A (zh) 2002-08-21
US6964970B2 (en) 2005-11-15
BR0011121A (pt) 2002-02-26
EP1180030B1 (de) 2004-11-24
NZ515611A (en) 2004-05-28
AU773550B2 (en) 2004-05-27
NO20015722L (no) 2001-11-23
US6573272B1 (en) 2003-06-03
CO5370679A1 (es) 2004-02-27
HK1045644A1 (zh) 2002-12-06
DE60016198T2 (de) 2005-12-01
NO20015722D0 (no) 2001-11-23
JP2003500448A (ja) 2003-01-07
AR024158A1 (es) 2002-09-04
WO2000072846A1 (en) 2000-12-07
HUP0201206A3 (en) 2003-07-28
MXPA01012326A (es) 2002-07-30
EP1180030A1 (de) 2002-02-20
US20030232850A1 (en) 2003-12-18
CA2375630A1 (en) 2000-12-07
JP4733836B2 (ja) 2011-07-27
EP1180030A4 (de) 2002-09-25
IL146514A0 (en) 2002-07-25
CZ20014290A3 (cs) 2002-05-15
HUP0201206A2 (en) 2002-08-28
KR20020005767A (ko) 2002-01-17
TR200103485T2 (tr) 2002-04-22
AU5177400A (en) 2000-12-18

Similar Documents

Publication Publication Date Title
DE60031682D1 (de) Antibakterielle verbindungen
ATE283049T1 (de) Antibakterielle verbindungen
DE60042286D1 (de) Pyrimidinon Verbindungen
EE200100502A (et) Ühendid
DE60031481T8 (de) Polymer-gebundene funktionelle Verbindungen
DE60210782D1 (de) Glukokinase beeinflussende verbindungen
EE200200224A (et) Uudsed ühendid
DE50004593D1 (de) Formmassen
ATE405580T1 (de) Antithrombotische verbindungen
NO20020621D0 (no) Antibakterielle midler
ATE258921T1 (de) Aryl-annellierte azapolycyclische verbindungen
MXPA01011760A (es) Compuestos novedosos de difeniletileno.
ID29533A (id) Senyawa-senyawa kalsilitik
NO20020466L (no) Kalsilytiske forbindelser
ATE405574T1 (de) Aryl-annellierte azapolyzyklische verbindungen
NO20014262D0 (no) Tiazoloindolinon-forbindelser
ID29984A (id) Senyawa-senyawa bis-stirilbifenil
SE9901117D0 (sv) Novel compounds
SE9904651D0 (sv) Novel compounds
SE9903838D0 (sv) Novel compounds
SE9903080D0 (sv) Novel compounds
SE9902903D0 (sv) Novel compounds
SE9901118D0 (sv) Novel compounds
SE9901271D0 (sv) Novel compounds
SE9901270D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties